Early research (Phase 1)UnknownNCT04631835What this trial is testingPhase I Study of the HS-10352 in Patients With Advanced Breast CancerWho this might be right forBreast Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT01439282What this trial is testingEribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast CancerWho this might be right forEstrogen Receptor Positive TumorBreast Cancer Eisai Inc. 77
Testing effectiveness (Phase 2)Looking for participantsNCT07314073What this trial is testing[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast CancerWho this might be right forStage III Breast Cancer Asan Medical Center 85
Not applicableUnknownNCT05734950What this trial is testingBiological Characteristics of Older Women (> 70 Years) With ER Positive, HER2 Negative Early Breast CancerWho this might be right forBreast Cancer Female Royal Marsden NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01381874What this trial is testingAbiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole TherapyWho this might be right forMetastatic ER+ Her2- Breast CancerPostmenopausal Janssen Research & Development, LLC 297
Testing effectiveness (Phase 2)Study completedNCT02216786What this trial is testingStudy of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerWho this might be right forEstrogen Receptor Positive Breast Cancer Queen Mary University of London 333
Testing effectiveness (Phase 2)Study completedNCT03839823What this trial is testingStudy to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Novartis Pharmaceuticals 222
Large-scale testing (Phase 3)Active Not RecruitingNCT01349322What this trial is testingHigher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by SurgeryWho this might be right forBreast Cancer Radiation Therapy Oncology Group 2,354
Testing effectiveness (Phase 2)Looking for participantsNCT05305924What this trial is testingFulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast CancerWho this might be right forER-Positive Breast CancerHER2-negative Breast Cancer The Methodist Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT03644186What this trial is testingTo Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)Who this might be right forBreast CancerEstrogen Receptor Positive TumorHER2-positive Breast Cancer ETOP IBCSG Partners Foundation 147
Testing effectiveness (Phase 2)Study completedNCT02530424What this trial is testing"Neo-Adjuvant Treatment With Palbociclib: Effect on Ki67 and Apoptosis Before, During and After Treatment "Who this might be right forBreast Neoplasms Fondazione Michelangelo 102
Large-scale testing (Phase 3)Active Not RecruitingNCT04964934What this trial is testingPhase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Who this might be right forER-Positive HER2-Negative Breast Cancer AstraZeneca 315
Testing effectiveness (Phase 2)Study completedNCT01216176What this trial is testingA Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast CancerWho this might be right forBreast Cancer Joyce Marie Slingerland, MD 71
Early research (Phase 1)Active Not RecruitingNCT04270149What this trial is testingCancer Peptides Plus GM-CSF and Adjuvant in Breast CancerWho this might be right forBreast Cancer Herbert Lyerly 8
Testing effectiveness (Phase 2)Ended earlyNCT03566485What this trial is testingAtezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerWho this might be right forStage III Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+4 more Vanderbilt-Ingram Cancer Center 12
Early research (Phase 1)Study completedNCT01009437What this trial is testingRitonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Masonic Cancer Center, University of Minnesota 28
Not applicableNot Yet RecruitingNCT06882499What this trial is testingStereotactic Ablative Body Radiotherapy (SABR) With Maintenance of Systemic Therapy Versus Physicians' Choice of Systemic Therapy for Oligoprogressive ER-positive, Her-2 Negative Breast Cancer IIWho this might be right forBreast Cancer, MetastaticMetastatic Breast Cancer Peter MacCallum Cancer Centre, Australia 74
Testing effectiveness (Phase 2)Study completedNCT05101564What this trial is testingUmbrella Trial of Subtype-Targeted Therapies in ER+/HER2- Breast CancerWho this might be right forBreast CancerHER2-negative Breast CancerER Positive Breast Cancer Jennifer Lee Caswell-Jin 19
Large-scale testing (Phase 3)Study completedNCT03096847What this trial is testingStudy for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast CancerWho this might be right forAdvanced Metastatic Breast Cancer Novartis Pharmaceuticals 502
Early research (Phase 1)Study completedNCT02684032What this trial is testingAssess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerWho this might be right forBreast Cancer Celcuity Inc 141